Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00002789Phase 3Completed
A Phase 3 trial of peripheral blood stem cells in chronic myeloid leukemia (CML), sponsored by Fred Hutchinson Cancer Center. Started May 1996; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00002789.